High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir: Integrated analysis of HCV genotype 1-6 patients without cirrhosis

March 21, 2018

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir: Integrated analysis of HCV genotype 1-6 patients without cirrhosis

Published on 03/20/2018

previous post: Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: A randomized clinical trial
next post: Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up